Entering text into the input field will update the search result below

Regeneron (NASDAQ:REGN) gets a 1.5% premarket lift from an upgrade to Overweight from Neutral at...

Jul. 01, 2013 7:53 AM ETRegeneron Pharmaceuticals, Inc. (REGN) StockREGNBy: Colin Lokey, SA News Editor
Regeneron (NASDAQ:REGN) gets a 1.5% premarket lift from an upgrade to Overweight from Neutral at Piper. Price target: $274.

Recommended For You

More Trending News

About REGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
REGN--
Regeneron Pharmaceuticals, Inc.